Tuesday, December 19, 2017

Weds Cure Talk: Targeting Stem Cells in Multiple Myeloma for Improved Outcomes

Multiple myeloma remains incurable despite improved remissions with novel agents. Relapse eventually occurs in the form of a drug-resistant disease that carries a dismal prognosis. Relapse is dependent on stem cell functions. We are talking to Dr. William Matsui of Johns Hopkins University School of Medicine to get a better understanding of the drivers of these functions and how they may lead to novel therapies for relapsed disease. 





No comments:

Post a Comment

Is this swollen

In the never ending quest to fight my crap immune system and ward off warts, my dermatologist is trying all kinds of stuff on my fingers. We...